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Besides oxidizing -arginine, neuronal NO synthase (NOS)
NADPH-dependently reduces various electron acceptors, in-
cluding cytochrome c and tetrazolium salts. The latter NADPH
diaphorase reaction is used as a NOS-specific histochemical
stain. Both reductase activities have been utilized to analyse
electron transfer mechanisms within NOS. Basal -arginine
turnover by homodimeric NOS is enhanced by exogenous
tetrahydrobiopterin, and the intra-subunit electron flow may
include intermediate trihydrobiopterin. In the present work we
have investigated the possible role of the tetrahydrobiopterin
binding site of NOS in its reductase activities by examining
the effects of anti-pterin type (PHS) NOS inhibitors. Although the
type I anti-pterin, PHS-32, which does not affect basal dimeric
NOS activity, also had no effect on either reductase activity, the
INTRODUCTION
Nitric oxide (NO) plays an important role both in physiology, as
a signal molecule in the central nervous and cardiovascular
systems [1–4], and in pathophysiology, as a cytotoxin in immune
and auto-immune responses [5]. NO is generated by three
genetically distinct NO synthases (NOS), neuronal (NOS-I),
inducible (NOS-II) and endothelial (NOS-III) [6]. All three
catalyse the conversion of -arginine to -citrulline and NO,
NO− (nitroxyl) or related N oxides [7–9]. However, they exhibit
important differences in their modes of expression and activity
regulation. NOS-I and NOS-III are constitutively expressed,
whereas, in most cells, NOS-II expression requires transcriptional
induction, e.g. by cytokines [6]. Enzyme activity of the con-
stitutively expressed isoforms (NOS-I and NOS-III) is stimulated
by elevated intracellular levels of free Ca#+ and calmodulin
(CaM) [10,11], although some degree of Ca#+-independent
activation can be detected upon phosphorylation [12–14].
In contrast, the activity of NOS-II is independent of changes in
intracellular free Ca#+, as CaM is tightly bound [15].
NOS is a homodimer, and only the homodimeric conformation
of NOS converts -arginine [16]. Each monomer consists of both
a reductase and a mono-oxygenase domain. The reductase
domain binds NADPH and, via prosthetic FAD and FMN
groups, mediates the transfer of an electron to a catalytically
active haem within the oxygenase domain [17]. In addition to
Abbreviations used: CaM, calmodulin ; CHAPSO, 3-[(3-cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propanesulphonate ; H4Bip, (6R)-5,6,7,8-
tetrahydro-L-biopterin ; MTS, 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulphophenyl) tetrazolium salt ; NBT, Nitro Blue Tetrazolium;
NOS, NO synthase; PHS-72 etc., anti-pterin sub-types ; SOD, superoxide dismutase ; TEA, triethanolamine.
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type II anti-pterin, PHS-72, which inhibits basal NOS activity,
inhibited both reductase activities and the NADPH diaphorase
histochemical stain. Pterin-free NOS monomers catalysed both
cytochrome c and tetrazolium salt reduction. Our data suggest
that both NOS reductase activities are independent of tetra-
hydrobiopterin. However, occupation of an exosite near the
pterin site in NOS by type II anti-pterins may interfere with
the electron flow within the active centre, suggesting that steric
perturbation of the pterin binding pocket or reductase interaction
contribute to the mechanism of inhibition by this class of NOS
inhibitors.
Key words: anti-pterins, diaphorase, nitric oxide, NO synthase
mechanisms, tetrahydrobiopterin.
NADPH, FAD and FMN, the intra-subunit electron flow may
include intermediate trihydrobiopterin reduction [18]. At the
oxygenase domain, the physiological substrate, -arginine, binds
to the enzyme and is oxidized [19,20]. The coupling mechanism
between the oxygenase and reductase domains is unclear, but is
thought to occur close to the pterin binding site [18,21].
One approach to gain insight into the NOS reaction mechanism
has been to dissect the overall reaction into partial reactions and
to analyse each individually. These reactions include the re-
duction of molecular oxygen to reactive oxygen species (NADPH
oxidase) and the reduction of cytochrome c and tetrazolium salts
[e.g. Nitro Blue Tetrazolium (NBT)] [22]. The reduction of NBT
(Figure 1) to a water-insoluble formazan, also termed the
NADPH diaphorase reaction, is resistant to aldehyde-based
protein fixatives and has been used as a histochemical stain for
NOS-I in fixed tissue sections [23,24]. Enzyme kinetic analysis of
the NBT reductase}NADPH diaphorase activity of NOS has
been hampered by the insolubility of the resulting formazan, thus
requiring the addition of organic solvents and semiquantitative
assay conditions to measure product formation [23,25]. In order
to assay the NADPH diaphorase activity of NOS continuously,
we developed a method using the tetrazolium salt 5-(3-carboxy-
methoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulphophenyl)
tetrazolium (MTS). Reduction of MTS leads to a water-soluble
formazan complex and thus does not require organic solvents for
spectrophotometric quantification [26,27]. Cytochrome c, the
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Figure 1 NADPH diaphorase substrates of NOS
Chemical structure of the tetrazolium salts MTS, generating a water-soluble formazan, and NBT,
generating a water-insoluble formazan.
second reductase substrate, has been shown to bind directly to
NOS-I and to be reduced in an NADPH- and Ca#+}CaM-
dependent manner [22].




-arginine conversion [28,29]. The precise function of this redox-
active compound in NOS is not entirely clear ; it may act as a
radical scavenger to stabilize the active site [30] and play a more
direct role within each electron transfer cycle [18]. Since H
%
Bip is
not stoichiometrically consumed during -arginine turnover, the
latter hypothesis implies intramolecular pterin reduction and
H
%
Bip regeneration. Thus the H
%
Bip binding site of NOS may be
spatially linked to one of the reductase activities of the enzyme.
Direct analysis of the role of H
%
Bip in this interaction is perturbed
by enzyme-independent, chemical interaction of H
%
Bip with the
redox-sensitive reductase substrates, e.g. tetrazolium salts. One
recent approach to study the role of H
%
Bip in -arginine turnover
and NO synthesis was the utilization of pterin-derived NOS
inhibitors [30,31]. These can be divided into two major categories :
type I anti-pterins (PHS), such as PHS-32 [30–32], which compete
with exogenous H
%
Bip, displace endogenous H
%
Bip and inhibit
NOS to the basal activity observed in the absence of exogenously
added H
%
Bip, and type II anti-pterins, such as PHS-72 [30–32],
which abolish NOS activity completely and bind to NOS without
displacing H
%
Bip, presumably by binding to the free binding site
of the partially H
%
Bip-saturated enzyme. Based on molecular-
field analysis of their structure–activity relationship and co-
crystallization data (H. Matter, P. Kotsonis, C. S. Raman, W.
Pfleiderer and H. H. H. W. Schmidt, unpublished work), this is
most likely due to their binding to a hydrophobic exosite adjacent
to the NOS pterin binding site [31,32]. To analyse the NOS pterin
binding site and reductase interaction within NOS, we examined
the effects of prototypical type I and type II anti-pterins on the
reduction of cytochrome c and MTS by purified neuronal NOS-
I, and compared these results with the possible effects of anti-
pterins on the NADPH diaphorase histochemical stain.
EXPERIMENTAL
Materials
NADPH, catalase and Cu}Zn superoxide dismutase (SOD) were
purchased from Roche Molecular Biochemical (Mannheim,
Germany) ; cytochrome c, Nω-nitro--arginine, 3-[(3-cholamido-
propyl)-dimethylammonio]-2-hydroxy-1-propanesulphonate
(CHAPSO) and triethanolamine hydrochloride (TEA) were
from Sigma (Deisenhofen, Germany) ; H
%
Bip was from Dr
Schircks Laboratories (Jona, Switzerland) ; MTS was from
Promega (Madison, WI, U.S.A.) ; -[2,3,4,5-$H]arginine HCl
(2.85 TBq[mmol−") was from Amersham (Braunschweig, Ger-
many); the PhastGel Silver Kit, for silver staining PhastGel
SDS}PAGE gels of purified NOS-I, was from Pharmacia
Biotech (Freiburg, Germany). All other chemicals were of the
highest purity available and obtained from either Sigma or
Merck AG (Darmstadt, Germany). Water was deionized to
18 MΩ[cm in a Milli-Q apparatus (Millipore, Eschborn,
Germany). Anti-pterins were synthesized as described previously
[31,32].
Purification of native porcine NOS-I
Porcine cerebellum NOS-I was prepared as described previously
[16,33], with slight modifications [34]. The purification protocol
included ammonium sulphate precipitation of a 100000 g crude
supernatant fraction followed by 2«,5«-ADP–Sepharose affinity
chromatography. To obtain only the dimeric enzyme, NOS-I was
further purified by gel-filtration chromatography. For this step,
the eluate from the 2«,5«-ADP–Sepharose affinity chroma-
tography (approx. 26 ml) was concentrated (Centriprep 30;
Amicon, Witten, Germany) to approx. 1 ml, centrifuged at
10000 g for 10 min at 4 °C and applied to a Superose 6 HR
10}30 gel-filtration column (Pharmacia Biotech, Freiburg, Ger-
many) operated by an FPLC system (Pharmacia Biotech). Gel
filtration was performed at 4 °C at a flow rate of 0.5 ml [min−"
in the presence of a 20 mM TEA}HCl buffer (pH 7.5) containing
0.5 mM EDTA, 150 mM NaCl, 10% (v}v) glycerol and 0.05%
CHAPSO. Protein was monitored spectrophotometrically at
A
#)!
. NOS-dimer-containing fractions were assayed for -ar-
ginine turnover, and cytochrome c reductase and MTS reductase
activities. The purity of NOS-I was determined by SDS}PAGE.
Fractions with purity & 90% were pooled, divided into portions
and stored at ®80 °C before use. Pure NOS-I had a specific
activity of 268.1³2.9 nmol citrulline[mg−"[min−".
Recombinant human NOS-I
Recombinant human NOS-I [35] was expressed in a baculo-
virus}Sf9 cell system [31], and purified to a specific activity of
643.0³13.7 nmol of citrulline[mg−" [min−" by using 2«,5«-ADP–
Sepharose and CaM-affinity chromatography sequentially, as
described previously [16,35].
Synthesis and UV/visible absorption spectra of the MTS-derived
formazan
To establish a quantitative MTS reductase assay, the enzyme-
independent, direct chemical reduction of tetrazolium salts by
H
%
Bip was utilized. Aqueous stock solutions of MTS (5–50 µM)
were converted to its formazan by adding H
%
Bip in a 10-fold
molar excess (50–500 µM). Subsequently, the A
%*!
of different
MTS concentrations was monitored against H
%
Bip blanks with a
UV}visible spectrophotometer (Hitachi U 2000; Hitachi, Lorch,
Germany). An excellent linear correlation between the amount
of MTS formazan and absorbance was found over the whole
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concentration range (for three experiments, each performed in
triplicate, r#¯ 0.99). A
%*!
was therefore used to quantify NOS-
catalysed MTS reduction. Calculations of total formazan were
made using a molar absorption coefficient (ε
%*!
) of 2.52³
1.4¬10% M−" [ cm−".
MTS reductase assay
MTS was freshly dissolved in 50 mM TEA}HCl buffer (pH 7.0).
These MTS stock solutions were protected from light and kept
on ice for immediate use. MTS reductase activity was assayed in
96-well microtitre plates by measuring the NOS-catalysed re-
duction of 2 mM MTS to its water-soluble formazan in a 100 µl
reaction volume containing 0.1 mM NADPH in 50 mM TEA}
HCl buffer (pH 7.0). Reactions were started by the addition of
70–80 ng of purified NOS-I. After an incubation period of 15 min
at 37 °C, with protection from light, the A
%*!
was measured using
a ThermoMax Microplate Reader (Molecular Devices, Menlo
Park, CA, U.S.A.). Blanks for each concentration of MTS were
measured in the absence of enzyme and subsequently subtracted
from the values obtained in the presence of NOS.
Cytochrome c reductase assay
Determination of cytochrome c reductase activity was modified
from a method described previously [22]. Stock solutions
of cytochrome c andNADPHwere freshlymadeon the dayof use.
Cytochrome c turnover was measured spectrophotometrically by
the NOS-catalysed reduction of 0.2 mM cytochrome c in 100 µl
of 50 mM TEA}HCl buffer (pH 7.0) containing 100 µM CaCl
#
,
100 nM CaM and 0.1 mM NADPH. Reactions were started by
the addition of 70–80 ng of purified NOS and continued at 37 °C
for 25 min. The total amount of reduced cytochrome c was
calculated using a molar absorption coefficient (ε
&&!
) of 2.1¬
10% M−" [ cm−".
Determination of L-arginine turnover
NOS-catalysed -arginine turnover was determined by measuring
-[$H]citrulline production from -[$H]arginine as described
previously [36], with modifications [34]. Assays were performed in
a reaction mixture containing 50 mM TEA}HCl buffer (pH 7.5),
20 µM -arginine (including 5.55 kBq -[2,3,4,5-$H]arginine),
1 mM NADPH, 5 µM FAD, 10 µM FMN, 50 nM CaM, 1 mM
CaCl
#
and 2 µM H
%
Bip. Blank values were determined in the
absence of enzyme. Incubations were performed at 37 °C for
15 min. The reaction was terminated by addition of stop buffer
containing 20 mM sodium acetate (pH 5.5) and 2 mM EDTA at
4 °C. [$H]Citrulline, and thus total -arginine to -citrulline
conversion, was subsequently measured by liquid scintillation
spectroscopy as described previously [31].
Generation and separation of NOS monomers and dimers
Under native conditions, -arginine conversion in the absence of
H
%
Bip leads to NOS monomerization. NOS monomers and
dimers can then be separated by size-exclusion chromatography
and investigated further [30]. To generate NOS monomers,
homodimeric recombinant human NOS-I (17 µg) was pre-
incubated at pH 7.0 in the presence of 25 mM -arginine, 1 mM
NADPH, 5 µM FAD, 10 µM FMN, 500 nM CaM, 1 mM CaCl
#
,
250 µM CHAPSO and 0.5 M TEA}HCl. The final incubation
volume was 100 µl. Incubations were carried out at 37 °C for
15 min and stopped by the addition of 10 µl of ice-cold 5 mM
EGTA. Immediately thereafter, samples were mixed, frozen in
liquid nitrogen and stored at ®80 °C. After thawing, samples
were centrifuged at 10000 g for 10 min at 4 °C, and analysed
by Superose 6 HR 10}30 size-exclusion chromatography as
described previously [30,31]. NOS dimers were eluted at
12.58³0.05 ml, monomers at 14.09³0.06 ml, corresponding to
Stokes’ radii of 7.89³0.01 nm and 6.07³0.06 nm, which was in
agreement with published values [16]. The two eluates were
divided into aliquots of 300 µl, which contained purely dimeric
or monomeric NOS.
NADPH diaphorase histochemical stain
Sprague–Dawley rats were anaesthetized and perfused intra-
aortically with mixed aldehyde fixatives. Vibratome sections of
the spinal cord, 25–50 µm thick, were incubated for 15 min in the
presence of either 200 µM anti-pterin dissolved in DMSO or
vehicle alone for control experiments. NADPH diaphorase
staining was performed as described previously [24,37,38].
Sections were incubated at 37 °C for 1.5 h in a mixture of 0.1%
(w}v) NADPH, 0.02% (w}v) NBT and 0.3% (v}v) Triton X-
100 in phosphate buffer (pH 7.4). Staining, using this proto-
col, co-localizes with immunocytochemically-defined NOS-I
[24,37,38] and concentrates in lamina II–III of the superficial
dorsal horn of the spinal cord [39–42].
Determination of protein
Protein concentrations were determined according to Bradford
[43] using BSA as a standard.
Statistics
All results are expressed as means³S.E.M.. Non-linear re-
gression analysis was performed using the Prism 2.0 software
package (GraphPad, San Diego, CA, U.S.A.).
RESULTS
Characterization of MTS and cytochrome c reductase activities
To establish MTS reductase as a novel on-line assay for the
NADPH diaphorase activity of NOS, we examined the ability of
native porcine NOS-I to reduce MTS. The NADPH dependency
of this activity was then characterized in comparison with the
established cytochrome c reductase and -arginine-to-citrulline
activities of NOS.
Purified porcine cerebellum NOS-I (0.6 µg), in the presence of
1 mM NADPH, was incubated with increasing concentrations
of MTS (10 µM–3.2 mM), as described in the Experimental
section, and the A
%*!
was measured after 30 min of incubation at
37 °C. The data were fitted to a sigmoidal concentration-response
curve (results of four individual experiments performed in
triplicate ; r#¯ 0.99), which indicated the saturable, enzymic
formation of formazan. NOS-I thus reduced MTS to a water-
soluble formazan complex in a concentration-dependent manner
with a K
m
[MTS] value of 600.8³1.1 µM and a specific activity
(V
max
) of up to 1.8 µmol mg−" [min−".
Thereafter, NOS-I was assayed for MTS (50 ng of NOS-I) and
cytochrome c (75 ng of NOS-I) reductase activities. Reductase
activities, at 37 °C, were monitored over 30 min at 1 min intervals
and total amounts of formazan and reduced cytochrome c were
calculated. Linear regression analysis was performed for three
experiments, each performed in triplicate. MTS reductase activity
remained stable over a period of 15 min, and declined thereafter ;
cytochrome c turnover was linear for at least 30 min. The
kinetics of MTS turnover thus resembled those of -arginine
turnover, which is also linear for approx. 15 min under similar
conditions.
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Table 1 Comparison of distinct NOS activities
L-Citrulline formation, MTS reduction and cytochrome c reduction by purified porcine cerebellum
NOS-I were determined, as described in the Experimental section, in the presence of various
concentrations of NADPH and CaM. Subsequently, non-linear regression analysis was
performed to calculate Ka or Km values. All activities were NADPH-dependent ; however, only
cytochrome c and citrulline formation were enhanced by the addition of Ca2+/CaM.
Km NADPH (µM) EC50 CaM (nM) Vmax (nmol [min−
1 [mg−1)
Citrulline formation 10.3³3.2 5.3³1.5 268³3
MTS reduction 20.9³1.7 No dependence 1370³170
Cytochrome c reduction 9.9³6.4 14.1³1.2 5489³213
Figure 2 Effects of CaM on cytochrome c and MTS reductase activities of
NOS-I
Purified porcine cerebellum NOS-I (140 ng) was incubated in the absence or presence of CaM
(0.1 nM–2 µM) with either cytochrome c (E) or MTS (D). All other assay conditions were
the same as described in the Experimental section. Control values were determined in the
absence of CaM. Each value represents the mean³S.E.M. of three individual experiments, each
performed in triplicate. The effects of increasing concentrations of Ca2+/CaM on cytochrome
c reductase activity were analysed by fitting a sigmoidal concentration response curve to the
data points (r 2 ¯ 0.99). Cytochrome c reduction by NOS-I was found to be greatly enhanced
by Ca2+/CaM in a concentration-dependent manner, whereas the formation of MTS-derived
formazan was not significantly affected.
To further characterize the MTS reductase assay, we de-
termined the apparent K
m
value for NADPH and compared it
with the respective value in the cytochrome c assay. NOS-I
(140 ng) was incubated with MTS or cytochrome c, as described
in the Experimental section, with increasing concentrations of
NADPH (100 nM–10 mM). Both MTS and cytochrome c re-
ductase activities were NADPH-dependent with K
m
[NADPH]
values in the same range as for -arginine turnover (Table 1).
Non-linear regression analysis was performed and resulted in a
sigmoidal concentration response curve for both MTS (r#¯
0.98) and cytochrome c turnover (r#¯ 0.98).
Ca2+/CaM was without effect on MTS turnover, but stimulated
cytochrome c reduction
MTS reductase activity was independent of CaM in the range of
0.1 nM to 2 µM, in the presence of saturating Ca#+ concentrations
(Figure 2). Conversely, cytochrome c reductase activity was
largely dependent on Ca#+}CaM (Figure 2), which stimulated
basal cytochrome c reduction approx. 9-fold. The half-maximally
effective concentration (EC
&!
) of CaM for stimulating cyto-
Figure 3 Effect of SOD and catalase on cytochrome c and MTS reductase
activity of NOS-I
(A) Cytochrome c (D, in the presence of 100 µM CaCl2 and 100 nM CaM;E, in the absence
of Ca2+/CaM) and MTS (]) reductase activities were determined in the presence of purified
porcine cerebellum NOS-I (115 ng) and increasing concentrations of SOD [10–5000 units
(U)[ml−1]. MTS reduction was found to be significantly inhibited by SOD, whereas cytochrome
c turnover was affected neither in the presence nor in the absence of Ca2+/CaM. (B)
Cytochrome c (D, in the presence of 100 µM CaCl2 and 100 nM CaM) and MTS reductase
(E) activities were determined as above, but in the presence of increasing concentrations of
catalase (0.1–1000 units[ml−1) instead of SOD. No effect of catalase was observed on
cytochrome c or on MTS reduction, arguing against a role for H2O2 in the reductase activities
of NOS-I. All other assay conditions were the same as described in the Experimental section.
Activity is expressed as a percentage of the respective control, e.g. in the presence of
Ca2+/CaM, and in the absence of SOD or catalase. Data points represent means³S.E.M.
of three individual experiments, each performed in triplicate. The asterisk (*) indicates significant
difference from the respective control, P ! 0.01.
chrome c reduction by NOS was similar to its EC
&!
value for
stimulating citrulline formation (Table 1).
Effects of SOD on MTS and cytochrome c reductase activities
The extend to which NOS reductase activities are mediated by
intermediate superoxide (O−
#
) formation is controversial [44,45].
To address this issue, the effects of SOD on MTS and cytochrome
c reductase activities of native porcine NOS-I were investigated.
SOD inhibited MTS reduction at concentrations as low as
100 units [ml−". At 1000 units [ml−", inhibition by SOD was
maximal (50% of control). In contrast, even the highest con-
centration of SOD tested (5 k-units [ml−") had no effect on the
Ca#+}CaM-stimulated reduction of cytochrome c (Figure 3A).
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Figure 4 Effect of type I and II anti-pterins on MTS and cytochrome c
reductase activities of purified porcine NOS-I
(A) Purified porcine cerebellum NOS-I (70 ng) was incubated in the presence of MTS (2 mM),
NADPH (0.1 mM), and various concentrations of PHS-32 (D) or PHS-72 (E). The type II anti-
pterin PHS-72 significantly inhibited MTS reductase activity, whereas the type I anti-pterin PHS-
32 had no effect. Control values were determined in the absence of anti-pterins and in the
presence of NOS and solvent (10% DMSO). The activity of the samples is expressed as a
percentage of the respective control. Data points represent means³S.E.M. of three individual
experiments, each performed in triplicate. (B) Purified porcine cerebellum NOS-I (70 ng) was
incubated in the presence of cytochrome c (0.2 mM), NADPH (0.1 mM), CaCl2 (100 µM), CaM
(100 nM) and various concentrations of PHS-32 (D) or PHS-72 (E). The anti-pterin II PHS-
72 significantly inhibited cytochrome c reductase activity of NOS-I, whereas the anti-pterin
PHS-32 had no effect. Except for the addition of DMSO and anti-pterins, assay conditions were
as described in the Experimental section. Controls contained enzyme and solvent (10% DMSO),
but no anti-pterins. Activity is reported as a percentage of Vmax. Data points represent
means³S.E.M. of three experiments, each performed in triplicate. The asterisk (*) indicates
significant difference from control, P ! 0.001.
Since a portion of cytochrome c reduction isCaM-independent,
we also characterized this basal activity. However, up to 5 k-
units [ml−" SOD had no effect on cytochrome c reduction,
regardless of whether Ca#+}CaM was present or not, suggesting
that neither basal nor CaM-stimulated reduction of cytochrome
c is mediated by O−
#
(Figure 3A).
Catalase affects neither MTS nor cytochrome c reduction
Instead of intermediate O−
#





Z. Shutenko, M. Feelisch and H. H. H. W. Schmidt, unpublished
work), which may interfere with MTS or cytochrome c reduction.
Therefore the effects of various concentrations of catalase
(0.1–1000 units [ml−") on MTS and cytochrome c reductase
activities were examined. However, catalase affected neither
MTS nor cytochrome c reduction (Figure 3B). Thus the lack of
Figure 5 Effect of anti-pterins on NADPH diaphorase histochemical stain
Vibratome sections of rat spinal cord, known to contain high levels of neuronal NO synthase
(NOS-I), were processed for NADPH diaphorase activity, as described in the Experimental
section, after incubation with 200 µM anti-pterin or vehicle. Control staining (A) without anti-
pterin was concentrated in laminae II–III of the dorsal horn. Preincubation of sections with
200 µM PHS-32 (B) showed the same staining pattern as the control, whereas pre-treatment
with 200 µM PHS-72 (C) markedly inhibited NADPH diaphorase staining. Data are representative
of three independent experiments.
effect of SOD on the cytochrome c reductase of NOS cannot be





Effects of anti-pterins on MTS and cytochrome c reduction
To investigate the possible role of NOS-associated H
%
Bip or the
NOS pterin binding site for the two NOS reductase activities
studied, we examined the effect of one prototypic compound for
each of the two classes of anti-pterin on MTS and cytochrome c
reduction. Figure 4(A) shows the effect of type I (PHS-32) and
type II (PHS-72) anti-pterins on MTS reductase activity of native
NOS-I, expressed as a percentage of the control, i.e. without
added anti-pterin. PHS-32 had no effect on MTS turnover in
concentrations of up to 400 µM. Conversely, PHS-72 induced
a significant, concentration-dependent inhibition of formazan
formation down to 60% of control.
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Table 2 Expression of MTS and cytochrome c reductase activity by both
pterin-containing dimers and pterin-free monomers
Recombinant human NOS-I (17 µg) was separated into pterin-containing dimers and pterin-free
monomers by size-exclusion chromatography as described in the Experimental section.
Subsequently, 40 µl (L-arginine conversion, cytochrome c reduction) and 50 µl (MTS
reduction) of the same dimer and monomer peak fractions were assayed for citrulline formation,
MTS and cytochrome c reductase activities as described in the Experimental section. The values
represent absolute amounts of product formed [min−1 [ml−1 ; n.d., not detectable.
Monomeric NOS-I Dimeric NOS-I
Citrulline formation (pmol) n.d. 19.3³0.1
MTS reduction (pmol) 1850³270 2000³130
Cytochrome c reduction (pmol) 8620³100 8580³300
The effects of the same anti-pterins on cytochrome c reductase
activity of native porcine NOS-I are shown in Figure 4.
Similarly to MTS reduction, the type I PHS-32, in concentrations
of up to 200 µM, had no significant effect on cytochrome c
reduction. In contrast, the type II PHS-72 significantly decreased
cytochrome c turnover in a concentration-dependent manner. At
200 µM, this compound diminished cytochrome c reduction to
8% of the control value. These data suggest a selective inhibitory
effect of type II anti-pterins, which occupy not only the NOS
pterin binding site in a H
%
Bip-competitive manner, but also an
adjacent, hydrophobic exosite. The latter is not competitive with
H
%
Bip, and may interfere sterically with subdomain interactions,
e.g. oxygenase}reductase coupling.
The effects of anti-pterins are preserved in the NADPH
diaphorase histochemical stain
An assay in itro for NADPH diaphorase activity of neuronal
NOS using MTS can only be an approximation of the reactions
which occur during the NADPH diaphorase histochemical
staining procedure using NBT. Therefore we investigated the
effects of the different anti-pterins on NADPH diaphorase stains
with NBT in neuronal tissue sections (Figure 5). Staining in the
absence of anti-pterins (Figure 5A) was concentrated in lamina
II–III of the superficial dorsal horn. In the presence of 200 µM
of type I PHS-32 (Figure 5B), the NADPH diaphorase stain
remained unaffected, showing the same staining pattern as the
control sections (Figure 5A). However, 200 µM of the type II
PHS-72 (Figure 5C) almost abolished NADPH diaphorase
activity staining in the tissue sections. These findings are con-
sistent with the data derived from the MTS assay in itro, and
strengthen the hypothesis thatMTS is a substrate for theNADPH
diaphorase reaction and that this activity is selectively altered by
the type II PHS-72.
Both pterin-containing dimers and pterin-free monomers of NOS-I
have MTS and cytochrome c reductase activity
H
%
Bip is also involved inNOSdimer stabilization [30], but present
data do not allow differentiation of the possible roles for H
%
Bip
in MTS and cytochrome c reductase activities in dimeric and
monomeric NOS-I. Thus recombinant human NOS-I was
separated into pterin-containing dimers (6.13³0.39 pmol H
%
Bip
per fraction) and pterin-free monomers. Both states of NOS,
dimeric and monomeric, occur during NOS-catalysed -arginine
turnover [30] or can be generated in the presence of various
protein denaturants, such as SDS [46] or urea [47]. However,
both NOS-I dimers and monomers were competent for MTS and
cytochrome c turnover (Table 2), suggesting that these NOS
activities are pterin-independent but are affected by pterin exosite
occupation by the type II PHS-72.
As we observed cytochrome c turnover by monomeric NOS,
we investigated whether NOS monomers also required Ca#+}
CaM to reduce cytochrome c. We therefore incubated monomeric
NOS, as described above, with and without CaCl
#
(100 µM) and
CaM (100 nM). In the absence of both Ca#+ and CaM, only
24.89³2.42% of the V
max
, i.e. the activity in the presence of Ca#+
and CaM, was observed in three experiments, each performed in
triplicate. The electron flow to the haem in monomeric NOS
therefore also appears to be regulated by CaM.
DISCUSSION
In addition to -arginine oxidation, NOS NADPH-dependently
reduces artificial electron acceptors such as tetrazolium salts [23],
cytochrome c [22] and others [45]. The reduction of the tetra-
zolium salt NBT to a water-insoluble formazan complex, termed
the NADPH diaphorase reaction, is widely used as a selective
histochemical marker for NOS-I in aldehyde-fixed sections of
neuronal and other tissues [23,48,49]. Yet it is mechanistically
not understood which domain in NOS mediates this reaction.
In the present work, we demonstrate that purified porcine
cerebellar NOS also reduces the tetrazolium salt MTS. Using
MTS as an electron acceptor to quantify NADPH diaphorase
activity has the advantage of forming a water-soluble formazan
complex, which allows enzyme kinetic analysis. NOS-dependent
formation of MTS formazan mirrored the kinetics of -arginine
to -citrulline conversion [34]. Similarly to the reduction of NBT,
MTS turnover showed an absolute requirement for NADPH. As
both substrates are tetrazolium salts, MTS can be considered as
an alternative substrate for the NADPH diaphorase activity of
NOS-I. This is corroborated by the qualitatively similar inhibition
pattern of anti-pterins on all three reductase activities, cyto-
chrome c reductase MTS reductase and NADPH diaphorase.
Calmodulin triggers the flavin-to-haem electron transfer be-
tween the reductase and oxygenase domains of the enzyme [50],
increases the rate of electron transfer into the flavins [51], and is
therefore essential for maximal -arginine-to--citrulline con-
version. The reduction of cytochrome c, but not that of MTS,
was enhanced by CaM in a concentration-dependent manner.
This profound difference in Ca#+}CaM-mediated catalysis of
MTS and cytochrome c emphasizes the important and specific
role of CaM binding between the haem and flavin-binding
domains of all NOSs. Calmodulin presumably affects the orient-
ation of these domains, thereby modulating and de-inhibiting
[45] electronic coupling of the reductase-to-oxygenase domain.
In contrast, the effects of Ca#+}CaM on the NADPH dia-
phorase activity of NOS remain unclear. NBT formazan form-
ation is generally believed to be Ca#+}CaM-independent,
although one report found it to be increased by Ca#+}CaM [44].
In our hands, MTS reduction was independent of Ca#+}CaM,
consistent with most other reports [25]. The possibility exists that
enzyme-bound H
%
Bip is oxidized by MTS (see the Experimental
section), thus influencing the CaM sensitivity of the enzyme.
However, this would imply an interference in the H
%
Bip and the
CaM binding sites, which has not been observed experimentally
[52]. Furthermore, NOS is only partially saturated with en-
dogenously bound H
%
Bip [30,31], so that changes in the H
%
Bip
redox state should only affect a sub-fraction of purified enzyme.
Thus H
%
Bip oxidation is unlikely to account for the observed
differences in the CaM dependence between MTS and cyto-
chrome c reductase activities.
It has been shown that Ca#+}CaM increases cytochrome c
reduction by NOS up to 10–15 fold, whereas it stimulates the rate
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of reduction of the artificial electron acceptors 2,6-dichloro-
phenolindophenol and ferricyanide only slightly or not at all [45].
This is in good agreement with our present data on both the
CaM-dependence of cytochrome c reduction and the CaM-
independence of MTS reduction. Since the formation of -
citrulline from -arginine is CaM-dependent, cytochrome c
reduction appears to follow a similar mode of electron transfer,
despite the fact that direct protein–protein interaction occurs
[22]. Moreover, a variety of electron acceptors (natural and
artificial) interfere with NO formation, because of the low
substrate specificity of the reductase domain of NOS [22].
Presumably, due to competition with molecular oxygen for
NADPH-derived electrons, these acceptor molecules inhibit -
citrulline formation in a concentration-dependent manner
[23,44].
The role of intermediate superoxide for the cytochrome c
reductase activity of NOS-I, in addition to direct protein–protein
interaction, remains a matter of debate [44,45]. Ca#+}CaM
stimulates the NADPH-dependent reduction of cytochrome c by
NOS in a SOD-sensitive manner (500 units of SOD [ml−"),
suggesting that cytochrome c reduction is mediated by inter-
mediate superoxide [45]. However, others have found that
NOS directly binds and reduces cytochrome c in an SOD-
insensitive manner [22,44] when using up to 1000 units of
SOD [ml−". In the present study, both the basal (Ca#+}CaM-
independent) and the CaM-dependent cytochrome c reductase
activities were SOD- as well as catalase-insensitive, arguing





the NADPH-dependent cytochrome P450 reductase [22,53,54].
Furthermore, the lack of effect of SOD on basal cytochrome c
turnover indicates that themechanisms of cytochrome c reduction
are similar in the presence and absence of Ca#+}CaM.
Conversely, the MTS reductase activity of NOS was, at least
in part, mediated by O−
#




. Based on our results,
approximately half of the NOS-catalysed MTS reduction was
mediated by direct transfer of electrons to MTS, fulfilling the
definition of an NADPH diaphorase reaction, whereas the other
half was reduced by NOS-derived superoxide anions. In the case
of the NADPH diaphorase histochemical stain, the latter reaction
might be excluded because of the presence of SOD in neuronal
cells, thus resulting in the apparently uniform behaviour of this
reaction in situ. This may also explain why PHS-72 is a more
effective inhibitor of the NADPH diaphorase histochemical
reaction when compared with the MTS reductase activity of
purified NOS.
Recently, the concept of a stoichiometric redox role for H
%
Bip
[18,55] in catalytically active NOS has been put forward. The
intermediate formation of H
$
Bipd, yet with almost full recovery
of H
%
Bip, requires that H
%
Bip is recycled by an intrinsic reductase
activity. This reductase activity should occur independently of
Ca#+}CaM (and at higher rates than H
%
Bip consumption), and
thus be different from Ca#+}CaM-dependent oxygen activation
by NOS. In order to clarify the role of enzyme-associated pterin
or the NOS pterin binding site per se in the two reductase
activities of NOS investigated, the effects of recently developed
anti-pterins [31,32] on cytochrome c and MTS reductase activities
were tested (see Figure 4). PHS-32, a type I anti-pterin, which
displaces & 80% of the endogenously bound H
%
Bip [30,31]
without being a partial agonist itself, was without effect on MTS
or on cytochrome c turnover. This suggested that H
%
Bip neither
has a direct role in the electron transfer leading to the reduction
of MTS and cytochrome c by native NOS-I nor does it compete
with these substrates. However, a recent study detected an
enzyme-bound H
$
Bipd-radical by EPR analysis [55]. A unifying
hypothesis of both this and our findings [8] suggests that H
%
Bip
Scheme 1 Schematic representation of the effects of H4Bip and anti-
pterins on the reductase activities of NOS
H4Bip-containing NOS monomers and dimers reduce cytochrome c, MTS and NBT by using
NADPH as a source for electrons (I). These reductase activities remain intact after removing
H4Bip from the enzyme (II). The type I anti-pterin, PHS-32, replaces endogenously bound H4Bip
from its binding site, but preserves the reductase activities of the enzyme (III). PHS-72, a type
II anti-pterin, is unable to displace endogenously bound H4Bip but binds to unoccupied pterin
binding sites and the adjacent exosite of NOS. The latter is suggested to disrupt the electron
flow of the enzyme, which is required for both reductase activities of NOS (IV).
is not necessarily involved in the electron flow and -arginine
turnover of the enzyme but helps in coupling NADPH oxidation




instead of NO− and O−
#
, in
the presence or absence of -arginine respectively), resulting in
the transient formation of a pterin radical.
PHS-72, a type II anti-pterin, does not readily displace
endogenous H
%
Bip. In analogy to NOS-I-catalysed -arginine
turnover, the inhibitory effect of PHS-72 seems to originate from
possible conformational changes of the enzyme and}or blockade
of an exosite by the bulky substituents at the C-6 and C-7
position of type II anti-pterins [31,32]. This structure–activity
relationship was recently confirmed by comparative molecular-
field analysis (H. Matter, W. Pfleiderer and H. H. H. W. Schmidt,
unpublished work). Thus type II anti-pterins may disrupt electron
flow from within the pterin binding pocket of the enzyme,
without a need to interfere directly with endogenous H
%
Bip
(Scheme 1). This might also explain the stronger effect of PHS-
72 on cytochrome c versus MTS reduction. However, NOS
reductase activities do not depend on protein-associated pterin,
as both pterin-free monomers and pterin-containing dimers of
recombinant human NOS-I expressed similar MTS and cyto-
chrome c reductase activities (see Table 2). Monomeric NOS
may re-assemble to form dimeric enzyme, which is only functional
for MTS}cytochrome c, but not for -arginine conversion.
However, this seems unlikely as neither -arginine nor H
%
Bip
were present in our incubation mixtures. In previous studies in
our laboratory [30] and in other laboratories [47,56–58], re-
dimerization of NOS monomers was not found in the absence of
both -arginine and H
%
Bip. It is thus generally accepted that
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monomeric neuronal NOS absolutely depends on the presence of
-arginine to form the dimeric enzyme. Reduction of MTS
(Ca#+}CaM-independently) and of cytochrome c (Ca#+}CaM-
dependently) by monomeric NOS-I is in agreement with a
previous study [58] reporting cytochrome c reductase activity of
monomeric NOS-II. Most interestingly, cytochrome c reductase
activity in monomeric NOS was also dependent on the presence
of CaM. The CaM-binding site therefore seems to be intact in
the NOS monomer, and electron flow can occur between the
reductase and the oxygenase domains upon Ca#+}CaM binding.
We thus conclude that NOS displays distinct reductase ac-
tivities with respect to their Ca#+}CaM dependence, SOD and
anti-pterin sensitivity. In none of them does NOS-associated
H
%
Bip play a role. However, occupation of the NOS pterin
binding site and adjacent exosite by the type-II PHS-72 interferes
with the intrasubunit electron flux, possibly by affecting
oxygenase}reductase coupling. With the resolution of the struc-
ture of the oxygenase domains of two NOS isoforms [18,21],
anti-pterins will be a valuable tool to analyse further the
Ca#+}CaM-dependent coupling of this domain to the reductase
site and intermediate H
$
Bipd formation.
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